Fake employees are an emerging cybersecurity threat. Learn how they infiltrate organizations and what steps you can take to ...

Discover why RGA Investment Advisors added Capital One (COF) to portfolios after its Discover acquisition. Read how this deal ...

Firefly plans to launch its lander toward the moon’s South Pole by the end of 2026. Assuming it arrives in one piece, the ...

The Berlin-based bridging and swap infrastructure provider has now raised $51.7M in total funding and processed more than $60B in onchain volume.

Running a synchrotron light source is a massive team effort that brings hundreds of highly skilled and specialized professionals together. The radiofrequency (RF) group at the National Synchrotron ...

In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically ...

In DUBLIN-3 non-squamous EGFR WT NSCLC patients who progressed after anti-PD-(L)1, Plinabulin + docetaxel showed consistent and clinically meaningful improvements in OS, PFS, and ORR, reinforcing ...

Trial deployment with leading California utility aims to address mounting grid challenges from data center demand, extreme ...

The Ethernet Alliance has released its 2026 Ethernet Roadmap, outlining the key multi-terabit technology developments and trends expected to shape high-performance, AI-driven networking over the ...

Daiichi Sankyo has announced the dosing of first patient in the DESTINY-Ovarian01 Phase III trial’s randomisation phase, ...

During the mailbag portion, Draymond was asked by one fan what he thought about the list of 50 power forwards, which Kenyon said were better than him. Green didn't seem like he was in the mood for a ...

Zanubrutinib and venetoclax combination shows an 87% 36-month PFS rate in CLL/SLL patients, regardless of del (17p)/TP53 or IGHV status. The SEQUOIA trial demonstrates durable minimal residual disease ...